Jiuzhou Pharmaceutical: Hydrobromide Vortioxetine Tablets Obtains Drug Registration Certificate

MetaMuskRat · 2026-03-17T17:35:32+00:00

People's Finance News, March 16 — Jiuzhou Pharmaceutical ((603456)) announced on March 16 that recently, its wholly-owned subsidiary Jiuzhou Biomedical (Taizhou) Co., Ltd. received a drug registration certificate for Vilazodone Hydro bromide Tablets, approved and issued by the National Medical Products Administration. Vilazodone Hydro bromide Tablets are primarily used for the treatment of major depressive disorder (MDD) in adults.

MetaMuskRat

2026-03-17 17:35:32

People’s Financial News, March 16 — Jiuzhou Pharmaceutical (603456) announced on March 16 that recently, its wholly-owned subsidiary Jiuzhou Biopharmaceutical (Taizhou) Co., Ltd. received the drug registration certificate approved and issued by the National Medical Products Administration for Hydrobromide Vilazodone Tablets. These tablets are primarily used for the treatment of moderate to severe major depressive disorder (MDD) in adults.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes